A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer
A phase 2 trial of Aminoglutethimide in Prostate cancer, run by H. Lee Moffitt Cancer Center and Research Institute, recorded as terminated on the registry.
Overview
A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer is a phase 2 interventional study registered as NCT00006371 by H. Lee Moffitt Cancer Center and Research Institute, with 2 participants recorded, started 2000-05 and due to reach its primary completion in 2001-12. Interventions recorded: aminoglutethimide, ketoconazole, therapeutic hydrocortisone. Conditions recorded: Prostate Cancer.
Linked to the drug Aminoglutethimide because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialSafety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
Shares Prostate cancer and the tag pipeline.
- TrialPhase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).
Shares Prostate cancer and the tag pipeline.
- TrialPhase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer
Shares Prostate cancer and the tag pipeline.
- TrialEvaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
Shares Prostate cancer and the tag pipeline.
- TrialStudy of ACE-86225106 to Treat Patients With Advanced Solid Tumors
Shares Prostate cancer and the tag pipeline.
- TrialStudy of AZD0754 in Participants With Metastatic Prostate Cancer
Shares Prostate cancer and the tag pipeline.
- TrialFirst-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
Shares Prostate cancer and the tag pipeline.
- TrialStudy of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Shares Prostate cancer and the tag pipeline.